[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Butylscopolamine Bromide Market - Global Outlook and Forecast 2021-2027

April 2021 | 102 pages | ID: B7ADE9A76C60EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Butylscopolamine Bromide in Global, including the following market information:

Global Butylscopolamine Bromide Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Butylscopolamine Bromide market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Butylscopolamine Bromide companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Butylscopolamine Bromide Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Butylscopolamine Bromide Market Segment Percentages, By Type, 2020 (%)
  • Tablets
  • Capsule
  • Intramuscular Injection
  • Intravenous Or Drip
  • Suppositories
  • Other
China Butylscopolamine Bromide Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Butylscopolamine Bromide Market Segment Percentages, By Application, 2020 (%)
  • Stomach
  • Gas Barium Hypography
  • Abdominal CT Scan
  • Gastrointestinal Spasm
  • Biliary Colic
  • Renal Colic
  • Gastrointestinal Hypermotility
  • Other
Global Butylscopolamine Bromide Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Butylscopolamine Bromide Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Butylscopolamine Bromide Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Butylscopolamine Bromide Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Sanofi
  • Boehringer Ingelheim
  • Sandoz (Novartis)
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • XI AN TIANXINGJIAN PHARMCHEM
  • Linnea
  • Alkaloida
  • Chengdu Tiantaishan Pharmaceutical
  • Jiangsu Ange Pharmaceutical
  • Chengdu First Pharmaceutical
  • Beijing Zizhu Pharmaceutical
  • Guangdong Zhongsheng Pharmaceutical
  • Wanbangde Pharmaceutical Group
  • Shandong Yijian Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Butylscopolamine Bromide Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Butylscopolamine Bromide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BUTYLSCOPOLAMINE BROMIDE OVERALL MARKET SIZE

2.1 Global Butylscopolamine Bromide Market Size: 2021 VS 2027
2.2 Global Butylscopolamine Bromide Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Butylscopolamine Bromide Players in Global Market
3.2 Top Global Butylscopolamine Bromide Companies Ranked by Revenue
3.3 Global Butylscopolamine Bromide Revenue by Companies
3.4 Top 3 and Top 5 Butylscopolamine Bromide Companies in Global Market, by Revenue in 2020
3.5 Global Companies Butylscopolamine Bromide Product Type
3.6 Tier 1, Tier 2 and Tier 3 Butylscopolamine Bromide Players in Global Market
  3.6.1 List of Global Tier 1 Butylscopolamine Bromide Companies
  3.6.2 List of Global Tier 2 and Tier 3 Butylscopolamine Bromide Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Butylscopolamine Bromide Market Size Markets, 2021 & 2027
  4.1.2 Tablets
  4.1.3 Capsule
  4.1.4 Intramuscular Injection
  4.1.5 Intravenous Or Drip
  4.1.6 Suppositories
  4.1.7 Other
4.2 By Type - Global Butylscopolamine Bromide Revenue & Forecasts
  4.2.1 By Type - Global Butylscopolamine Bromide Revenue, 2016-2021
  4.2.2 By Type - Global Butylscopolamine Bromide Revenue, 2022-2027
  4.2.3 By Type - Global Butylscopolamine Bromide Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Butylscopolamine Bromide Market Size, 2021 & 2027
  5.1.2 Stomach
  5.1.3 Gas Barium Hypography
  5.1.4 Abdominal CT Scan
  5.1.5 Gastrointestinal Spasm
  5.1.6 Biliary Colic
  5.1.7 Renal Colic
  5.1.8 Gastrointestinal Hypermotility
  5.1.9 Other
5.2 By Application - Global Butylscopolamine Bromide Revenue & Forecasts
  5.2.1 By Application - Global Butylscopolamine Bromide Revenue, 2016-2021
  5.2.2 By Application - Global Butylscopolamine Bromide Revenue, 2022-2027
  5.2.3 By Application - Global Butylscopolamine Bromide Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Butylscopolamine Bromide Market Size, 2021 & 2027
6.2 By Region - Global Butylscopolamine Bromide Revenue & Forecasts
  6.2.1 By Region - Global Butylscopolamine Bromide Revenue, 2016-2021
  6.2.2 By Region - Global Butylscopolamine Bromide Revenue, 2022-2027
  6.2.3 By Region - Global Butylscopolamine Bromide Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Butylscopolamine Bromide Revenue, 2016-2027
  6.3.2 US Butylscopolamine Bromide Market Size, 2016-2027
  6.3.3 Canada Butylscopolamine Bromide Market Size, 2016-2027
  6.3.4 Mexico Butylscopolamine Bromide Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Butylscopolamine Bromide Revenue, 2016-2027
  6.4.2 Germany Butylscopolamine Bromide Market Size, 2016-2027
  6.4.3 France Butylscopolamine Bromide Market Size, 2016-2027
  6.4.4 U.K. Butylscopolamine Bromide Market Size, 2016-2027
  6.4.5 Italy Butylscopolamine Bromide Market Size, 2016-2027
  6.4.6 Russia Butylscopolamine Bromide Market Size, 2016-2027
  6.4.7 Nordic Countries Butylscopolamine Bromide Market Size, 2016-2027
  6.4.8 Benelux Butylscopolamine Bromide Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Butylscopolamine Bromide Revenue, 2016-2027
  6.5.2 China Butylscopolamine Bromide Market Size, 2016-2027
  6.5.3 Japan Butylscopolamine Bromide Market Size, 2016-2027
  6.5.4 South Korea Butylscopolamine Bromide Market Size, 2016-2027
  6.5.5 Southeast Asia Butylscopolamine Bromide Market Size, 2016-2027
  6.5.6 India Butylscopolamine Bromide Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Butylscopolamine Bromide Revenue, 2016-2027
  6.6.2 Brazil Butylscopolamine Bromide Market Size, 2016-2027
  6.6.3 Argentina Butylscopolamine Bromide Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Butylscopolamine Bromide Revenue, 2016-2027
  6.7.2 Turkey Butylscopolamine Bromide Market Size, 2016-2027
  6.7.3 Israel Butylscopolamine Bromide Market Size, 2016-2027
  6.7.4 Saudi Arabia Butylscopolamine Bromide Market Size, 2016-2027
  6.7.5 UAE Butylscopolamine Bromide Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Butylscopolamine Bromide Major Product Offerings
  7.1.4 Sanofi Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.1.5 Sanofi Key News
7.2 Boehringer Ingelheim
  7.2.1 Boehringer Ingelheim Corporate Summary
  7.2.2 Boehringer Ingelheim Business Overview
  7.2.3 Boehringer Ingelheim Butylscopolamine Bromide Major Product Offerings
  7.2.4 Boehringer Ingelheim Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.2.5 Boehringer Ingelheim Key News
7.3 Sandoz (Novartis)
  7.3.1 Sandoz (Novartis) Corporate Summary
  7.3.2 Sandoz (Novartis) Business Overview
  7.3.3 Sandoz (Novartis) Butylscopolamine Bromide Major Product Offerings
  7.3.4 Sandoz (Novartis) Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.3.5 Sandoz (Novartis) Key News
7.4 Boehringer Ingelheim Pharma GmbH & Co. KG
  7.4.1 Boehringer Ingelheim Pharma GmbH & Co. KG Corporate Summary
  7.4.2 Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview
  7.4.3 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Major Product Offerings
  7.4.4 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.4.5 Boehringer Ingelheim Pharma GmbH & Co. KG Key News
7.5 XI AN TIANXINGJIAN PHARMCHEM
  7.5.1 XI AN TIANXINGJIAN PHARMCHEM Corporate Summary
  7.5.2 XI AN TIANXINGJIAN PHARMCHEM Business Overview
  7.5.3 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Major Product Offerings
  7.5.4 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.5.5 XI AN TIANXINGJIAN PHARMCHEM Key News
7.6 Linnea
  7.6.1 Linnea Corporate Summary
  7.6.2 Linnea Business Overview
  7.6.3 Linnea Butylscopolamine Bromide Major Product Offerings
  7.6.4 Linnea Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.6.5 Linnea Key News
7.7 Alkaloida
  7.7.1 Alkaloida Corporate Summary
  7.7.2 Alkaloida Business Overview
  7.7.3 Alkaloida Butylscopolamine Bromide Major Product Offerings
  7.4.4 Alkaloida Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.7.5 Alkaloida Key News
7.8 Chengdu Tiantaishan Pharmaceutical
  7.8.1 Chengdu Tiantaishan Pharmaceutical Corporate Summary
  7.8.2 Chengdu Tiantaishan Pharmaceutical Business Overview
  7.8.3 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Major Product Offerings
  7.8.4 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.8.5 Chengdu Tiantaishan Pharmaceutical Key News
7.9 Jiangsu Ange Pharmaceutical
  7.9.1 Jiangsu Ange Pharmaceutical Corporate Summary
  7.9.2 Jiangsu Ange Pharmaceutical Business Overview
  7.9.3 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Major Product Offerings
  7.9.4 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.9.5 Jiangsu Ange Pharmaceutical Key News
7.10 Chengdu First Pharmaceutical
  7.10.1 Chengdu First Pharmaceutical Corporate Summary
  7.10.2 Chengdu First Pharmaceutical Business Overview
  7.10.3 Chengdu First Pharmaceutical Butylscopolamine Bromide Major Product Offerings
  7.10.4 Chengdu First Pharmaceutical Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.10.5 Chengdu First Pharmaceutical Key News
7.11 Beijing Zizhu Pharmaceutical
  7.11.1 Beijing Zizhu Pharmaceutical Corporate Summary
  7.11.2 Beijing Zizhu Pharmaceutical Business Overview
  7.11.3 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Major Product Offerings
  7.11.4 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.11.5 Beijing Zizhu Pharmaceutical Key News
7.12 Guangdong Zhongsheng Pharmaceutical
  7.12.1 Guangdong Zhongsheng Pharmaceutical Corporate Summary
  7.12.2 Guangdong Zhongsheng Pharmaceutical Business Overview
  7.12.3 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Major Product Offerings
  7.12.4 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.12.5 Guangdong Zhongsheng Pharmaceutical Key News
7.13 Wanbangde Pharmaceutical Group
  7.13.1 Wanbangde Pharmaceutical Group Corporate Summary
  7.13.2 Wanbangde Pharmaceutical Group Business Overview
  7.13.3 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Major Product Offerings
  7.13.4 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.13.5 Wanbangde Pharmaceutical Group Key News
7.14 Shandong Yijian Pharmaceutical
  7.14.1 Shandong Yijian Pharmaceutical Corporate Summary
  7.14.2 Shandong Yijian Pharmaceutical Business Overview
  7.14.3 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Major Product Offerings
  7.14.4 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Revenue in Global (2016-2021)
  7.14.5 Shandong Yijian Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Butylscopolamine Bromide Market Opportunities & Trends in Global Market
Table 2. Butylscopolamine Bromide Market Drivers in Global Market
Table 3. Butylscopolamine Bromide Market Restraints in Global Market
Table 4. Key Players of Butylscopolamine Bromide in Global Market
Table 5. Top Butylscopolamine Bromide Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Butylscopolamine Bromide Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Butylscopolamine Bromide Revenue Share by Companies, 2016-2021
Table 8. Global Companies Butylscopolamine Bromide Product Type
Table 9. List of Global Tier 1 Butylscopolamine Bromide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Butylscopolamine Bromide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Butylscopolamine Bromide Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Butylscopolamine Bromide Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Butylscopolamine Bromide Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Butylscopolamine Bromide Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Butylscopolamine Bromide Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Butylscopolamine Bromide Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Butylscopolamine Bromide Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Butylscopolamine Bromide Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Butylscopolamine Bromide Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Butylscopolamine Bromide Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Butylscopolamine Bromide Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Butylscopolamine Bromide Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Butylscopolamine Bromide Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Butylscopolamine Bromide Revenue, (US$, Mn), 2022-2027
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Butylscopolamine Bromide Product Offerings
Table 32. Sanofi Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 33. Boehringer Ingelheim Corporate Summary
Table 34. Boehringer Ingelheim Butylscopolamine Bromide Product Offerings
Table 35. Boehringer Ingelheim Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 36. Sandoz (Novartis) Corporate Summary
Table 37. Sandoz (Novartis) Butylscopolamine Bromide Product Offerings
Table 38. Sandoz (Novartis) Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 39. Boehringer Ingelheim Pharma GmbH & Co. KG Corporate Summary
Table 40. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Product Offerings
Table 41. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 42. XI AN TIANXINGJIAN PHARMCHEM Corporate Summary
Table 43. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Product Offerings
Table 44. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 45. Linnea Corporate Summary
Table 46. Linnea Butylscopolamine Bromide Product Offerings
Table 47. Linnea Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 48. Alkaloida Corporate Summary
Table 49. Alkaloida Butylscopolamine Bromide Product Offerings
Table 50. Alkaloida Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 51. Chengdu Tiantaishan Pharmaceutical Corporate Summary
Table 52. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Product Offerings
Table 53. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 54. Jiangsu Ange Pharmaceutical Corporate Summary
Table 55. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Product Offerings
Table 56. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 57. Chengdu First Pharmaceutical Corporate Summary
Table 58. Chengdu First Pharmaceutical Butylscopolamine Bromide Product Offerings
Table 59. Chengdu First Pharmaceutical Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 60. Beijing Zizhu Pharmaceutical Corporate Summary
Table 61. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Product Offerings
Table 62. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 63. Guangdong Zhongsheng Pharmaceutical Corporate Summary
Table 64. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Product Offerings
Table 65. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 66. Wanbangde Pharmaceutical Group Corporate Summary
Table 67. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Product Offerings
Table 68. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)
Table 69. Shandong Yijian Pharmaceutical Corporate Summary
Table 70. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Product Offerings
Table 71. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Butylscopolamine Bromide Segment by Type
Figure 2. Butylscopolamine Bromide Segment by Application
Figure 3. Global Butylscopolamine Bromide Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Butylscopolamine Bromide Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Butylscopolamine Bromide Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Butylscopolamine Bromide Revenue in 2020
Figure 8. By Type - Global Butylscopolamine Bromide Revenue Market Share, 2016-2027
Figure 9. By Application - Global Butylscopolamine Bromide Revenue Market Share, 2016-2027
Figure 10. By Region - Global Butylscopolamine Bromide Revenue Market Share, 2016-2027
Figure 11. By Country - North America Butylscopolamine Bromide Revenue Market Share, 2016-2027
Figure 12. US Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Butylscopolamine Bromide Revenue Market Share, 2016-2027
Figure 16. Germany Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 17. France Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Butylscopolamine Bromide Revenue Market Share, 2016-2027
Figure 24. China Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 28. India Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Butylscopolamine Bromide Revenue Market Share, 2016-2027
Figure 30. Brazil Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Butylscopolamine Bromide Revenue Market Share, 2016-2027
Figure 33. Turkey Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Butylscopolamine Bromide Revenue, (US$, Mn), 2016-2027
Figure 37. Sanofi Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Boehringer Ingelheim Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sandoz (Novartis) Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Linnea Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Alkaloida Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Chengdu First Pharmaceutical Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications